The Diabetes Year In Review 2022 | DiabetesMine - guildwiffor

January

Medicare made the long-awaited and highly welcome decision to cover both the OmniPod tubeless insulin pump and the newborn Abbott Libre flash glucose monitoring arrangement. Because CMS (the Centers for Medicare and Medicaid Services) typically sets the stage for what private insurers will cover, this was a big win for PWDs (people with diabetes) of all ages!

As a nasty round of wildfires and mudslides plagued California, many diabetes orgs stepped up to help PWDs in need. In that respect were many "Diabetes Disaster Mode" lessons to be learned.

In the constant research for a diabetes cure, a novel approach appeared in the form of a spider's web. Yep, researchers at Cornell University came up with a concept to implant a sort of synthetic drawstring at heart the body that would allow clumps of insulin-producing islet cells to connect in a "beads on a string" social organisation, equal that of spider's silk. It's still in the R&D phase, of flow from.

A Colorado lawmaker became the ordinal (after Nevada and Mississippi) to introduce a bill mandating insulin pricing transparency in his State Department. These Drug Pricing Transparency Acts have become a base of the #insulin4all movement.

Feb

"Is my insulin poor?" That's a question many of USA enquire ourselves periodically, with no path of knowing. A controversial fresh study explored insulin concentration and potential supply chain problems that could intend the quality of insulin isn't up to par away the time information technology reaches patients.

The American Association of Diabetes Educators (AADE) got sedate around embracing patient peer support with some very public moves to make over a closer kinship with the DOC (Diabetes Online Profession) and other patient of groups. Congratulations to them! {Disclaimer: DiabetesMine was involved in this effort}

We got a casual to trial-trial the new Companion InPen "smart insulin pen" that can pucker and share dosing information. Verdict: it brings much of the cool powerful features of an insulin pump to pen users, but it's pricey.

We scored an interview with down in the mouth-carb pioneer Dr. Richard Leonard Bernstein, who at age 83 remains steadfast in his sentiment that "there is a carbist-conspiracy, and that carb use is the main perpetrator in the treatment of diabetes these days."

March

Medtronic announced that it was delivery binding its stand for-alone CGM with its Guardian 3 sensor — but oddly we've heard few rustling out there approximately this product since. The company appears to be leading everyone to its 670G pump-sensing element "hybrid closed-loop system" system instead, and in fact, we publicized drug user tips on that system this same calendar month.

Dexcom received Food and Drug Administration blessing for its G6 CGM poser in March also. (So mayhap MedT's Guardian announcement was no conjunction?) The Dexcom G6 became the first of its kind offering direct-to-phone smartphone connectivity, with no need for a separate receiver and no fingerstick calibrations required!

MannKind Corp. brought on a new CMO — Dr. Jacques Louis David Kendall formerly of Eli Lilly — to guarantee a bright future for Afrezza inhaled insulin. We got a sneak preview of their BluHale device nether developing, which wish bring in data trailing and connectivity to the Afrezza inhaler.

We interviewed the newest president of AADE (American language Association of Diabetes Educators), Donna Ryan, who brings important noesis of the glaring gaps in healthcare that survive for some of the poorest, underserved populations in our country.

On that note, AADE began to entrench to transporation barriers for people with diabetes: how can patients physically get to the care they need?

March is of course Women's History Calendar month, so we successful a project of creating a detailed Tribute to Women in Diabetes Chronicle, honoring a dozen-plus women from past and present WHO have made a positive mark on our D-Humankind.

April

Sanofi launched its newest Admelog insulin, a biosimilar "copycat reading" of Lilly's Humalog that's supposed to be available in U.S. pharmacies at the "lowest list price" of any meal-time insulin happening the market. This hasn't solved the Insulin Affordability Crisis, merely information technology's a step in the right direction.

The #insulin4all movement advocating on that crisis began really gaining steam in America, with help from sometime Envenom cradle Bret Michaels.

Meanwhile, big insulin maker Eli Lilly stepped into the islet encapsulation world, announcing a collaboration with Sigilon Therapeutics to develop implantable mini-capsules containing insulin-making isle cells that would go into a person's abdomen — lasting for leastwise a class without the need for immune suppressant dru medications.

May

Original standout country vocalizer Ben Herb of grace launched a "Buck Disconnected Diabetes" campaign with Roche Diabetes Care that promotes a cost-nest egg political program and supports donations to diabetes nonprofits.

DiabetesMine was invited to visit the Lilly Cambridge Innovation Center in Cambridge, MA, as part of a gathering of a dozen diabetes bloggers invited out to learn almost the company's vision for the future of insulin delivery — where we learned all about their new pump, pen and "ecosystem" plans.

We scarred Crataegus oxycantha as Status Mental Wellness Awareness Month by investigating what's being done to better plow the common jazz band of diabetes and mental health challenges.

The WNYC World Radio show Sugarland, a pretty darn amazing investigative series highlight the diabetes epidemic and skyrocketing insulin prices, actually got information technology rightish in distinguishing between T1 and T2. But it besides reignited the argumentation about the ask to revise those names.

June

The Solid ground Diabetes Tie-u's annual Scientific Sessions were held in Orlando, Sunshine State. We covered the action live on both hot new research presented and new applied science and products happening display. Tech stars of the express included the newly FDA approved InPen smart insulin pen, In tandem's Basal IQ pane adjusting package, OmniPod's upcoming bluetooth-enabled DASH system, and the new Eversense implantable CGM that's just reaching patients and creating a lot of buzz.

Along with those exciting approvals, Medicare at last spoke out stating it would support smartphone use for CGM and other diabetes tools — hugely polar for reporting going forward!

Zero indefinite stirs controversy quite like Dr. Denise Faustman, and this year, she even prompted an unprecedented cooperative statement from ADA and JDRF warning that her research findings may comprise overhyped.

We were privileged to connect with Nicole Smith-Holt, a D-mom WHO's become an extremely hands-on urge for afforable insulin after losing her 26-year-old son to DKA as a result of rationing insulin. Nicole is involved in pushy for drug pricing reclaim and transparentness legistation.

July

July is known Eastern Samoa CWD Friends for Life conference month and among the exciting stuff on the agendum this year was news of progress on the iLET Bionic Pancreas scheme from Beta Bionics. Their Gen 4 iLET closed-loop system system is in clinical trials now.

We also reported on how the market for rapid-acting glucagon products is acquiring a lot more interesting with a number of new options upcoming soon — including a nasal spray intersection and a prompt-to-use rescue pen filed with FDA in 2018 and supposed to hit market in the next year!

Meanwhile, the Food and Drug Administration announced that it is building a original evening gown infrastructure for enduring engagement, and both well-proverbial faces in our Diabetes Community are already tangled.

National honors were given to many of the folks involved in Diabetes Parking brake Relief Efforts following the sequential natural disasters in 2017 that rocked the Gulf Coast and Caribbean islands. Kudos to all those who stepped raised!

August

Another D-mom who tragically lost her T1D son launched a program called "Jesse Was Here" to support bereaved diabetes community members. Thanks to the fireball non-profit On the far side Type 1 for taking this program under their offstage, along with so some other initiatives.

Dexcom made a key acquisition in Virginia-supported startup TypeZero Technologies, a spin-off of University of Old Dominion closed loop topology technology research developing a closed-loop control algorithm run connected a smartphone app. This acquisition makes Dexcom a full-fledged player in the race to create an Coloured Pancreas system, rather than simply a supplier of indefinite critical component (CGM).

We investigated word that the long-anticipated Roche Solo spot ticker may finally be making it to marketplace soon…?

The FDA approved a overloaded 14 days of wear for the Abbott Freestyle Libre flash glucose monitoring device, a new type of CGM that's rocking some PWDs' worlds.

September

We published an in-depth review of Tandem's new BG predictive software called Basal IQ — our squad's have receive and also including glowing reviews from across the patient community. Some even called the system "frigging magical."

Diabetes care in prisons surfaced as a hot topic, with several new federal lawsuits filed, prompted past a few highly publicized deaths behind parallel bars.

Our community of interests lost a treasure in Dr. Lois Jovanovic, the Santa Babara-based endocrinologist WHO pioneered pregnancy hold dear women with diabetes. Lois changed so many lives with her enthusiastic manner and lively spirit, that made ruddy births possible for so many women who had lost hope.

Our own mothership, Healthline Media, published a study looking into the "State of T2 Diabetes" that was single in concentrating on the interpersonal and psychological aspects; we found it to be a real and true internal representation of life struggles with diabetes crossways the board.

October

We had the chance to question Tracey Brown, who in summer 2018 became the first female African-American CEO of the American Diabetes Connexion who is living with diabetes herself; she shared out her personal floor and what she envisions as a "amber start" for ADA.

In the meantime, we learned in late Oct that D-Dad Derek Rapp would comprise abdication next year as CEO of JDRF. In our interview with him, he was candid about what JDRF could do better.

In possibly one of the almost exciting developments of the year, open data nonprofit organization Tidepool kicked polish off a project to formally documentation Cringle, the currently DIY open root automated insulin delivery app for iPhone. This is BIG, because it marks the first time a crowdsourced DIY diabetes solution will morph into an "official" Food and Drug Administration-approved product, that can compete with offerings from established vendors.

The TV series 'The Resident' took happening insulin pricing in a floor line, and actually got it right. We interviewed the show's administrator manufacturer, who lives with type 1 himself and is one of three PWDs on staff of the popular medical dramatic play.

Are we ready for Inhaled Insulin 3.0? Terpsichore Pharmaceuticals based in the San Francisco Bay Area is restfully readying to launch a brand rising "soft mist" formulation, i.e. an ultra-concentrated recombinant insulin that requires entirely a few drops that are volatilized into mist form as you breath it deep into the lungs through a small handheld device.

And World Health Organization inevitably peer support, in any event? Apparently whol of us. During this Cancer Awareness Month, we heard from an impassioned Certified Diabetes Educator WHO lives with T1D herself, but never really appreciated peer bread and butter resources until she was diagnosed with ovarian cancer too.

November

There's always a caboodle leaving on during Domestic Diabetes Cognizance Calendar month and for World Diabetes Twenty-four hour period on Nov. 14, and this year was no exception.

In early November, we were also thrilled to host our annual DiabetesMine Innovation Summit and D-Data ExChange applied science assembly, united this year nether a new "DIABETESMINE UNIVERSITY" theme. Read all close to the amazing talks, workshops and demos here!

In the meantime, Microphone attended the CWD Friends for Life conference in Niagara Waterfall, Ontario, and observed that Canadians are just as hungry for diabetes info, camaraderie and support as we are Stateside.

Not surprising to some in our community, Verily (formerly Google Life Sciences) officially scrapped its project to develop glucose-perception contact lenses; apparently, "rip glucose and bloodline glucose don't correlate."

The popular next-gen "flash" glucose monitoring device Abbott Libre received US Food and Drug Administration approving for the LibreLink ambulant app allowing users to scan the sensor immediately from their smartphone, with none indigence to use the separate handheld receiver.

News also hit that OmniPod users will have smartphone control of that patch pump organisation before long — an electrifying option for insulin pumpers.

JDRF teamed awake with a lo of government to launch a "moonshot initiative" aimed at restoring vision in diabetes patients who've suffered eye-consanguineal complications. It's a longshot, but one well meriting pursuing.

Miss The States 2018 Brittany Wagner was on the touring in the name of diabetes advocacy, in honor of her father who passed away in part from long-term D-complications a decade ago.

December

The unreal Dr. Fran Kaufman is abdication as Of import Medic of Medtronic Diabetes — for attribute and job reasons. We talked with her all about IT.

DiabetesMine was proud to announce that our original research article exploring the impact of social media engagement connected lifetime with diabetes is at present live online at the Journal of Diabetes Science & Technology. The consider, conducted endure summer, is titled: "What Are PWDs (Mass with Diabetes Doing Online? A Netnographic Analysis."

We too looked into elder hold dear people with diabetes — peculiarly those on insulin — and learned that it's hospitable of a trainwreck. Conceive this a scream to action that better elder care for people with T1D is sorely required!

And per tradition, we "called the diabetes advocacy organizations to the mat" at the end of the year away asking them to share with the community what they've achieved this year, and what they hope to accomplish in the new year ahead. Read all about their big 2018 milestones and 2019 goals here.

What about you, Lamb Readers: Anything stand call at your minds from this past year that we might have missed? Let us be intimate…

And while we're at it, we want to hear from you just about how we'ray doing, striving to allow useful info and insights here at the 'Mine. As e'er, your input signal is more than wanted, so please send us your comments via email or ping us on social media.